No headlines found.
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
ACCESS Newswire (Tue, 4-Nov 10:00 AM ET)
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
ACCESS Newswire (Thu, 23-Oct 9:00 AM ET)
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Utah Medical Products trades on the NASDAQ stock market under the symbol UTMD.
As of December 31, 2025, UTMD stock price declined to $55.96 with 9,577 million shares trading.
UTMD has a market cap of $179.39 million. This is considered a Micro Cap stock.
In the last 3 years, UTMD traded as high as $101.41 and as low as $51.26.
The top ETF exchange traded funds that UTMD belongs to (by Net Assets): VTI, IWM, VXF, IWN, DFAT.
UTMD has underperformed the market in the last year with a price return of -6.1% while the SPY ETF gained +17.2%. UTMD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.6% and -4.2%, respectively, while the SPY returned +2.7% and +0.7%, respectively.
UTMD support price is $54.63 and resistance is $57.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that UTMD shares will trade within this expected range on the day.
